EyePoint Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.10.24	EyePoint Pharma Prices Public Offering Of About 12.73 Mln Shares At $11.00/shr (RTTNews)
28.10.24	PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday (Benzinga)
25.10.24	Analyst Ratings For EyePoint Pharmaceuticals (Benzinga)
13.08.24	EyePoint Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) (Benzinga)
07.05.24	Deep Dive Into EyePoint Pharmaceuticals Stock: Analyst Perspectives (4 Ratings) (Benzinga)
06.05.24	Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge (Benzinga)
06.05.24	EyePoint Stock Plunges 34% As Eye Treatment Fails To Meet Trial Goal (RTTNews)
06.05.24	Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday? (Benzinga)
08.03.24	Critical Insights From EyePoint Pharmaceuticals Analyst Ratings: What You Need To Know (Benzinga)
04.03.24	EyePoint Pharma CMO Dario Paggiarino Quits, Ramiro Ribeiro Named Replacement (RTTNews)
05.02.24	Biotech High-Flyers That Just Hit 52-Week Highs (RTTNews)
22.01.24	Unveiling 7 Analyst Insights On EyePoint Pharmaceuticals (Benzinga)
05.12.23	5 Analysts Have This to Say About EyePoint Pharmaceuticals (Benzinga)
05.12.23	EyePoint Pharmaceuticals, Hut 8 Mining, GitLab, Take-Two Interactive, Tesla: Why These 5 Stocks Are On Investors' Radars Today (Benzinga)
04.12.23	Why Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today? (Benzinga)
04.12.23	EyePoint's Phase 2 DAVIO 2 Trial Of EYP-1901 Achieves Primary, Secondary Endpoints In Wet AMD (RTTNews)
10.08.23	These 11 Biotech Stocks Hit New Highs - Are They In Your Portfolio? (RTTNews)
10.07.23	EyePoint Pharma Appoints Jay Duker As CEO (RTTNews)
23.01.23	EyePoint To Build 40K Sq. Ft. Facility To Make EYP-1901, YUTIQ (RTTNews)
04.01.23	EyePoint COO Jay Duker Gets Additional Responsibility Of President (RTTNews)
01.08.22	EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 DAVIO 2 Clinical Trial of EYP-1901 for the Maintenance Treatment of Wet AMD (PR Newswire)
15.07.22	EyePoint: 12-month Data From DAVIO Trial Reinforces Safety, Efficacy For EYP-1901 (RTTNews)
15.07.22	EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
12.02.22	EyePoint Pharmaceuticals Announces Updated Positive Interim Safety and Efficacy Data from Ongoing Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
15.11.21	Pre-market Movers: CREX, BTB, EYPT, OXBR, MICT… (RTTNews)
13.11.21	EyePoint Reports Positive Interim Data From Phase 1 Trial Of EYP-1901 On Wet AMD Treatment (RTTNews)
13.11.21	EyePoint Pharmaceuticals Reports Positive Interim Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD (PR Newswire)
04.01.21	Ocumension Therapeutics Invests $15.7 Mln In EyePoint Pharma (RTTNews)
27.10.20	ANAB, GSK Amend Agreement, BSGM Plunges As COVID-19 Trial Flops, CATB Craters, MRTX Abuzz (RTTNews)
04.09.20	Pre-market Movers In Healthcare Sector: SONN, OBSV, OSUR, CVAC, OCGN... (RTTNews)
27.08.20	Pre-market Movers In Healthcare Sector: EYPT, CLVS, ABT, VBIV, LPCN... (RTTNews)
25.08.20	Pre-market Movers In Healthcare Sector: OCGN, CERS, IBIO, KMDA, SONN… (RTTNews)
24.08.20	Pre-market Movers In Healthcare Sector: SONN, ADMA, THMO, LMNL, KMDA... (RTTNews)
04.08.20	Ausblick: EyePoint Pharmaceuticals präsentiert das Zahlenwerk zum abgelaufenen Jahresviertel (finanzen.net)
05.08.19	Ausblick: EyePoint Pharmaceuticals zieht Bilanz zum abgelaufenen Quartal (finanzen.net)
06.05.19	Ausblick: EyePoint Pharmaceuticals präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net)
12.03.19	Ausblick: EyePoint Pharmaceuticals öffnet die Bücher zum abgelaufenen Quartal (finanzen.net)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu EyePoint Pharmaceuticals Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten